| Mrs Heather Sacha Wheelock, CNM, WHNP | |
|
4320 Diplomacy Dr, Suite 2191, Anchorage, AK 99508-5925 | |
| (907) 729-5726 | |
| (907) 729-4389 |
| Full Name | Mrs Heather Sacha Wheelock |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 4320 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700140084 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 1310 (Alaska) | Primary |
| 163W00000X | Registered Nurse | 34597 (Alaska) | Secondary |
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
The risk to children's health from X-ray radiation is easy to reduce without compromising diagnostic accuracy. Gerhard Alzen and Gabriele Benz-Bohm describe some ways to achieve this in the current edition of Deutsches Ärzteblatt International.
Clinical results from a Phase IIb study showed that MK-4305, Merck's investigational dual orexin receptor antagonist, was significantly more effective than placebo (p<0.005) in improving overall sleep efficiency at night one and at the end of week four in patients with primary insomnia. MK-4305 was generally well-tolerated in the study. Orexins are neuropeptides (chemical messengers) that are released by specialized neurons in the hypothalamus region of the brain and are believed to be an important regulator of the brain's sleep-wake process.
New figures showing that second-hand smoke at work kills over 600 people every year in the UK leave no doubt that Liverpool is justified in its attempt to go smokefree, say doctors and nurses.
Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has joined with Gust Bardy, MD to create an innovation center focused on the development and commercialization of simple, cost-effective medical products and services that positively impact public health.
Millennium: The Takeda Oncology Company and, Takeda Pharmaceutical Company Limited today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for conditional approval of brentuximab vedotin for two indications.
› Verified 5 days ago
| Entity Name | Southcentral Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
The risk to children's health from X-ray radiation is easy to reduce without compromising diagnostic accuracy. Gerhard Alzen and Gabriele Benz-Bohm describe some ways to achieve this in the current edition of Deutsches Ärzteblatt International.
Clinical results from a Phase IIb study showed that MK-4305, Merck's investigational dual orexin receptor antagonist, was significantly more effective than placebo (p<0.005) in improving overall sleep efficiency at night one and at the end of week four in patients with primary insomnia. MK-4305 was generally well-tolerated in the study. Orexins are neuropeptides (chemical messengers) that are released by specialized neurons in the hypothalamus region of the brain and are believed to be an important regulator of the brain's sleep-wake process.
New figures showing that second-hand smoke at work kills over 600 people every year in the UK leave no doubt that Liverpool is justified in its attempt to go smokefree, say doctors and nurses.
Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has joined with Gust Bardy, MD to create an innovation center focused on the development and commercialization of simple, cost-effective medical products and services that positively impact public health.
Millennium: The Takeda Oncology Company and, Takeda Pharmaceutical Company Limited today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for conditional approval of brentuximab vedotin for two indications.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Heather Sacha Wheelock, CNM, WHNP 4320 Diplomacy Dr, Suite 2191, Anchorage, AK 99508-5925 Ph: (907) 729-5726 | Mrs Heather Sacha Wheelock, CNM, WHNP 4320 Diplomacy Dr, Suite 2191, Anchorage, AK 99508-5925 Ph: (907) 729-5726 |
News Archive
The risk to children's health from X-ray radiation is easy to reduce without compromising diagnostic accuracy. Gerhard Alzen and Gabriele Benz-Bohm describe some ways to achieve this in the current edition of Deutsches Ärzteblatt International.
Clinical results from a Phase IIb study showed that MK-4305, Merck's investigational dual orexin receptor antagonist, was significantly more effective than placebo (p<0.005) in improving overall sleep efficiency at night one and at the end of week four in patients with primary insomnia. MK-4305 was generally well-tolerated in the study. Orexins are neuropeptides (chemical messengers) that are released by specialized neurons in the hypothalamus region of the brain and are believed to be an important regulator of the brain's sleep-wake process.
New figures showing that second-hand smoke at work kills over 600 people every year in the UK leave no doubt that Liverpool is justified in its attempt to go smokefree, say doctors and nurses.
Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has joined with Gust Bardy, MD to create an innovation center focused on the development and commercialization of simple, cost-effective medical products and services that positively impact public health.
Millennium: The Takeda Oncology Company and, Takeda Pharmaceutical Company Limited today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for conditional approval of brentuximab vedotin for two indications.
› Verified 5 days ago
Ms. Jade Parnaby, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 4501 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-4955 | |
Ms. Debra Rosa Kristich-miskill, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3260 Providence Dr, Suite 520, Anchorage, AK 99508 Phone: 907-569-8810 Fax: 907-569-8813 | |
Amanda Lynn Ruff, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4141 Ambassador Dr, Anchorage, AK 99508 Phone: 907-729-3973 Fax: 907-729-1542 | |
Martha Jean Linden, C.N.M. Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2501 E 42nd Ave, Anchorage, AK 99508 Phone: 907-561-1925 | |
Amber Michael, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 4001 Lake Otis Pkwy Ste 101, Anchorage, AK 99508 Phone: 800-769-0045 | |
Janet A Froeschle, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4320 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-3100 Fax: 907-729-3170 | |
Zelda Louise Collett-paule, CNM, ANP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4320 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-3100 Fax: 907-729-3170 |